Abstract |
Human adenocarcinoma cells of the line WiDr have been treated with 2 mM 5-aminolaevulinic acid (5-ALA) in the presence of 10% foetal calf serum. The treatment induces a linear accumulation of protoporphyrin IX ( PpIX) for at least 7.5 h. After 7.5 h of incubation about 45% of the PpIX accumulated is cell-bound, while the rest is found in the medium (25%) or lost from the cells during washing with phosphate-buffered saline (30%). Exposure to white light at an intensity of 30 W/m2 for 18 min results in 95% reduction of clonogenicity in cells treated with 2 mM 5-ALA for 3.5 h. The enzymatic activities of enzymes located in cytosol ( glyceraldehyde 3-phosphate dehydrogenase and lactate dehydrogenase) and lysosomes ( acid phosphatase and beta-glucuronidase) are not influenced by a 5-ALA and light treatment inactivating about 35% of the cells. The MTT assay, which reflects mitochondrial dehydrogenase activity, but not succinate dehydrogenase, is partly inhibited by the same treatment. Treatment with 5-ALA in the absence of light increases O2 consumption by a factor of two, while the O2 consumption is inhibited when 5-ALA treatment is combined with exposure to light. In addition, 5-ALA and light exposure enhance accumulation of rhodamine 123 by 40% and reduce the intracellular ATP level by 25%. Confocal laser scanning microscopical analysis indicates granular perinuclear localization of the PpIX formed by 5-ALA treatment. In conclusion, photodynamic treatment using 5-ALA as a prodrug induces damage to mitochondrial function without inhibiting lysosomal and cytosolic marker enzymes.
|
Authors | O A Gederaas, M H Rasch, K Berg, J W Lagerberg, T M Dubbelman |
Journal | Journal of photochemistry and photobiology. B, Biology
(J Photochem Photobiol B)
Vol. 49
Issue 2-3
Pg. 162-70
(Apr 1999)
ISSN: 1011-1344 [Print] Switzerland |
PMID | 10392465
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- Fluorescent Dyes
- Heptanoates
- Photosensitizing Agents
- Protoporphyrins
- Rhodamine 123
- succinylacetone
- Aminolevulinic Acid
- Adenosine Triphosphate
- protoporphyrin IX
|
Topics |
- Adenosine Triphosphate
(metabolism)
- Aminolevulinic Acid
(therapeutic use)
- Biomarkers, Tumor
- Colonic Neoplasms
(drug therapy)
- Fluorescent Dyes
(pharmacokinetics)
- Heptanoates
(pharmacology)
- Humans
- Microscopy, Confocal
- Microscopy, Fluorescence
- Oxygen Consumption
(drug effects)
- Photochemotherapy
- Photosensitizing Agents
(therapeutic use)
- Protoporphyrins
(metabolism)
- Rhodamine 123
(pharmacokinetics)
- Time Factors
- Tumor Cells, Cultured
|